Shoreline Biosciences is a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune disorders and other serious diseases, utilizing proprietary iPSC-derived natural killer (iNK) cell and macrophage (iMACs) platforms
Shoreline Biosciences is a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune disorders and other serious diseases, utilizing proprietary iPSC-derived natural killer (iNK) cell and macrophage (iMACs) platforms.